My overall aim is to biochemically and genetically dissect the insulin gene transcriptional processes with special reference to repression of insulin gene expression. I have previously shown that the Adenoviral-5 Ela proteins inhibit pancreas beta-cell specific insulin gene transcription in vivo. The site of Ela-induced inhibition was within the rat insulin II gene enhancer element which is known to be required for tissue-specific expression of this gene. Accumulating evidence supports the hypothesis that cellular """"""""Ela-like"""""""" activities are important in regulating cellular gene transcription. To test this hypothesis for the insulin gene, I will determine whether cellular and viral proteins, with functional properties similar to Ela, will repress insulin gene transcription. I have recently shown that both HeLa and liver cell nuclear extracts contain a cellular trans-acting transcriptional factor(s) capable of repressing insulin gene transcription in vitro. To understand how these viral and cellular repressor factors modulate insulin gene transcription, I propose to: (1) identify the target DNA site/region of the insulin gene required for repression; (2) determine whether the repressor factors interact directly with the same cis-acting sequences required for repression in vivo; and (3) identify the regions within the Ela polypeptide which are responsible for repression.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29GM039257-02
Application #
3466651
Study Section
Molecular Biology Study Section (MBY)
Project Start
1988-07-01
Project End
1993-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203